These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16116132)

  • 1. Botulinum toxin injections do not improve freezing of gait in Parkinson disease.
    Wieler M; Camicioli R; Jones CA; Martin WR
    Neurology; 2005 Aug; 65(4):626-8. PubMed ID: 16116132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
    Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type B for gait freezing in Parkinson's disease.
    Fernandez HH; Lannon MC; Trieschmann ME; Friedman JH
    Med Sci Monit; 2004 Jul; 10(7):CR282-4. PubMed ID: 15232500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study.
    Giladi N; Gurevich T; Shabtai H; Paleacu D; Simon ES
    J Neurol; 2001 Jul; 248(7):572-6. PubMed ID: 11517998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomoxetine for freezing of gait in Parkinson disease.
    Jankovic J
    J Neurol Sci; 2009 Sep; 284(1-2):177-8. PubMed ID: 19361809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B; Földy D; Hefter H; Auff E; Schnider P
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of freezing of gait.
    Giladi N
    Mov Disord; 2008; 23 Suppl 2():S482-8. PubMed ID: 18668620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study.
    Lim EC; Quek AM; Seet RC
    Neurol Neurophysiol Neurosci; 2006 Jun; ():4. PubMed ID: 17260081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A injections for the treatment of hand tremors.
    Trosch RM; Pullman SL
    Mov Disord; 1994 Nov; 9(6):601-9. PubMed ID: 7845399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL; Gray DS; Burnham RS
    Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease.
    Schneider SA; Edwards MJ; Cordivari C; Macleod WN; Bhatia KP
    Mov Disord; 2006 Oct; 21(10):1722-4. PubMed ID: 16817198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action observation improves freezing of gait in patients with Parkinson's disease.
    Pelosin E; Avanzino L; Bove M; Stramesi P; Nieuwboer A; Abbruzzese G
    Neurorehabil Neural Repair; 2010 Oct; 24(8):746-52. PubMed ID: 20453155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.